We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+6.13%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$121B
AUM Growth
+$4.41B
(+3.8%)
Cap. Flow
-$1.62B
Cap. Flow
% of AUM
-1.34%
Top 10 Holdings %
Top 10 Hldgs %
30.67%
Holding
292
New
6
Increased
53
Reduced
180
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MFGP
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
|
+$415M |
| 2 |
Mattel
MAT
|
+$306M |
| 3 |
AstraZeneca
AZN
|
+$175M |
| 4 |
Alkermes
ALKS
|
+$173M |
| 5 |
Boeing
BA
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$317M |
| 2 |
NSR
Neustar Inc
NSR
|
+$240M |
| 3 |
Microsoft
MSFT
|
+$143M |
| 4 |
Honeywell
HON
|
+$139M |
| 5 |
Amgen
AMGN
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.84% |
| 2 | Healthcare | 23.94% |
| 3 | Industrials | 15.98% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Financials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
HubSpot
HUBS
$12.7B
| $44.5M | 0.04% |
528,850
-30,000
| -5% | -$2.15M |
|
177
GSK
GSK
$103B
| $43.7M | 0.04% |
860,428
| – | – |
|
178
TransDigm Group
TDG
$71.3B
| $43.5M | 0.04% |
170,300
+35,500
| +26% | +$9.61M |
|
179
OSI Systems
OSIS
$3.9B
| $38.8M | 0.03% |
424,300
-4,500
| -1% | -$366K |
|
180
Tyson Foods
TSN
$20.7B
| $37.4M | 0.03% |
531,100
| – | – |
|
181
Norfolk Southern
NSC
$76.7B
| $36.4M | 0.03% |
275,000
| – | – |
|
182
Stryker
SYK
$129B
| $32.3M | 0.03% |
227,500
| – | – |
|
|
BBBY
183
DELISTED
Bed Bath & Beyond Inc
BBBY
| $30.9M | 0.03% |
1,315,526
-36,086
| -3% | -$1.01M |
|
|
ONC
184
BeOne Medicines Ltd
ONC
$33.5B
| $30.2M | 0.03% |
292,005
+166,667
| +133% | +$12.4M |
|
|
SAVE
185
DELISTED
Spirit Airlines, Inc.
SAVE
| $29.3M | 0.02% |
877,924
-36,800
| -4% | -$1.47M |
|
|
IMGN
186
DELISTED
Immunogen Inc
IMGN
| $29.2M | 0.02% |
3,823,300
-59,200
| -2% | -$393K |
|
187
Standard BioTools
LAB
$321M
| $29.1M | 0.02% |
5,775,143
+1,491,300
| +35% | +$6.27M |
|
188
OraSure Technologies
OSUR
$287M
| $28.3M | 0.02% |
1,259,000
-1,000
| -0.1% | -$20.1K |
|
|
OMED
189
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $25.2M | 0.02% |
5,565,900
+12,300
| +0.2% | +$49.8K |
|
190
Arbutus Biopharma
ABUS
$873M
| $24.7M | 0.02% |
3,990,400
+40,000
| +1% | +$171K |
|
191
General Dynamics
GD
$104B
| $24.3M | 0.02% |
118,000
-225,000
| -66% | -$45.1M |
|
|
HA
192
DELISTED
Hawaiian Holdings, Inc.
HA
| $24.1M | 0.02% |
641,300
| – | – |
|
193
NOV
NOV
$7.13B
| $23.7M | 0.02% |
663,845
-179,000
| -21% | -$5.85M |
|
|
SIOX
194
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $23.5M | 0.02% |
426,350
+9,200
| +2% | +$1.55M |
|
|
ASNA
195
DELISTED
Ascena Retail Group, Inc.
ASNA
| $23M | 0.02% |
470,025
-24,180
| -5% | -$1.05M |
|
196
PepsiCo
PEP
$190B
| $22.3M | 0.02% |
200,000
| – | – |
|
197
Nutanix
NTNX
$16.6B
| $22.1M | 0.02% |
984,832
-2,600
| -0.3% | -$56.9K |
|
198
Celanese
CE
$4.96B
| $22M | 0.02% |
210,950
-950
| -0.4% | -$93.3K |
|
199
Accuray
ARAY
$37.2M
| $21.3M | 0.02% |
5,332,500
-7,000
| -0.1% | -$30.1K |
|
200
Cerus
CERS
$441M
| $21.3M | 0.02% |
7,800,000
| – | – |
|
Similar funds
VAM
Primecap Management's Q3 2017 Portfolio in Review
As of Q3 2017, Primecap Management held 292 positions worth $121B, up 3.8% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Primecap Management's Q3 2017 filing shows 6 new, 53 increased, 180 reduced and 13 closed positions. Its largest new stake was Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share: 10,747,710 shares worth $415M. The largest sale was NVIDIA, an estimated $317M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q3 2017 buy was Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share: 10,747,710 shares worth $415M.
- Primecap Management added most to Mattel in Q3 2017, an estimated $306M increase.
- Primecap Management's biggest Q3 2017 reduction was NVIDIA, cutting an estimated $317M.
- Primecap Management fully exited Neustar Inc in Q3 2017, selling an estimated $240M.
- Primecap Management's ten largest holdings make up 31% of its $121B portfolio in Q3 2017.
- Primecap Management opened 6 new positions and closed 13 in Q3 2017.
- Primecap Management's portfolio value rose 3.8% quarter-over-quarter to $121B.
Based on Primecap Management's 13F filing for Q3 2017, filed 13 Nov 2017.